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Abstract
A total of 242 genes were shown to be differentially expressed between haplotypically matched tumorigenic adenovirus 12 (Ad12) and
nontumorigenic Ad5-transformed cells using a microarray containing 8734 cDNAs. Eighty-seven of the differentially expressed genes have
known roles that include signal transduction, cell growth and proliferation, transcription regulation, protease, and immune functions. The
remaining differentially expressed genes are represented by EST cDNAs which have functions that are either completely unknown or
proposed, based on sequence similarity to known genes. A subset of 22 differentially expressed genes from the microarray was further
examined by Northern blot analyses to verify the identification of new genes associated with Ad12 tumorigenesis. Growth factor receptor
binding protein 10 (Grb10) and protease nexin 1 (PN-1) were overexpressed in all of the tumorigenic Ad12-transformed cells examined,
whereas expression of these genes was negligible in all of the nontumorigenic Ad5-transformed cells. By contrast, other genes including
B cell translocation gene 2 (BTG2) were shown to be significantly up-regulated in Ad5-transformed cells as compared to Ad12-transformed
cells.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
All human adenovirus serotypes, of which there are more
than 50, are capable of transforming nonpermissive rodent
cells in vitro (reviewed in Williams et al., 2003). Cellular
transformation by adenoviruses is governed by the E1A and
E1B genes that are responsible for activation of the cell
cycle and inhibition of growth arrest and apoptosis. How-
ever, only a subset of adenoviruses or their cell transfor-
mants are able to induce the formation of tumors in immu-
nocompetent adult rodents. Studies using tumorigenic
adenovirus type 12 transformed cells (Ad12-TC) have
shown a direct correlation between tumorigenesis and di-
minished expression of the major histocompatibity complex
(MHC) class I antigens on the cell surface. In this regard, it
is enlightening that the E1A gene of Ad12 mediates both
Ad12 tumorigenesis and class I antigen reduction. Dimin-
ished class I expression provides transformed cells with a
capacity to escape immunosurveillance by cytotoxic T lym-
phocytes (CTLs) (reviewed in McFadden and Kane, 1994;
Ricciardi, 1995, 1999). In contrast, expression of MHC
class I antigens is not reduced in nontumorigenic adenovirus
type 5-transformed cells (Ad5-TC).
Expression of class I antigens on Ad12-TC is blocked at
the level of transcription and is due to altered binding of
regulatory factors to the class I enhancer (Ge et al., 1992;
Kralli et al., 1992; Nielsch et al., 1992; reviewed in Ric-
ciardi, 1999). Specifically, there is decreased binding of
activator NF-B and increased binding of repressor COUP-
TFII to the enhancer (Hou et al., 2002; Kushner et al., 1996;
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Kushner and Ricciardi, 1999; Liu et al., 1994; Smirnov et
al., 2000, 2001). The converse occurs in nontumorigenic
Ad5-TC, i.e., class I transcription is stimulated by strong
binding of NF-B and lack of binding of COUP-TFII to the
class I enhancer (Ackrill and Blair 1989; Liu et al., 1994,
1996).
The distinction in tumorigenic potential between Ad12
and Ad5 involves not only the down-regulation of class I
transcription but also other biological processes. Ad12 E1A
contains a unique spacer segment composed of 20 amino
acids between two conserved regions referred to as CR2 and
CR3. This spacer region, which is not found in Ad5 E1A, is
essential for tumorigenesis by Ad12 but does not function in
MHC class I down-regulation. One possibility is that the
spacer region enables Ad12-transformed cells to escape
natural killer cells (reviewed in Williams et al., 2003). It is
interesting to note that Ad5 E1A C-terminal mutants that are
defective in CtBP binding are able to confer a tumorigenic
phenotype (reviewed in Chinnadurai, 2002).
cDNA microarray technology is a recently developed,
powerful tool that permits high-throughput analysis of gene
expression profiles (Schena et al., 1995; reviewed in van
Hal et al., 2000). This technique has been used successfully
in the identification of tumor-related genes for several hu-
man cancers (Chaib et al., 2001; Kitahara et al., 2001; Ono
et al., 2000; Sgroi et al., 1999). Such information revealed
by cDNA microarray analysis not only provides key clues to
the function of novel genes associated with tumors, but also
can lead to clearer understanding of the mechanisms under-
lying tumorigenesis.
In this study, we have applied cDNA microarray tech-
nology as a means to compare the expression profiles of
7854 unique genes between haplotypically matched nontu-
morigenic Ad5-TC and tumorigenic Ad12-TC. The mi-
croarray indicated that 242 cDNAs were differentially ex-
pressed between the tumorigenic and the nontumorigenic
cell lines. Several genes chosen from the microarray were
confirmed by Northern blot analyses as being highly differ-
entially expressed between tumorigenic and nontumorigenic
cells. The nature of these genes and their potential bearing
on Ad12 tumorigenesis is discussed.
Results and discussion
Identification of differentially expressed genes between
nontumorigenic Ad5-TC and tumorigenic Ad12-TC using
cDNA microarray
E1A is solely responsible for the difference in tumori-
genic potential between Ad5-TC and Ad12-TC (reviewed in
Ricciardi, 1999; Williams et al., 2003). To identify tumor-
related genes in Ad12-TC, we compared global gene ex-
pression profiles between two haplotypically matched
Ad5-TC and Ad12-TC (KAd5 and F10-12, respectively,
Table 1) using cDNA microarray. Both the nontumorigenic
KAd5 and the tumorigenic F10-12 cell lines are derived
from mouse BALB/c kidney primary cells. The use of
genetically identical cell lines minimizes variability in gene
expression levels unrelated to adenovirus transformation.
Microarray was used to serve as the first screen to iden-
tify candidate genes that are associated with tumorigenesis.
As outlined in Fig. 1A, the mouse GEM microarray con-
tained 8734 cDNAs that represent 7854 unique genes,
among which 3205 are annotated and 4649 are unannotated.
More than 89% of the cDNAs (7809 clones) on the microar-
ray yielded detectable signals. Changes in gene expression
greater than twofold are considered to be “meaningful”
(reviewed in van Hal et al., 2000.). Based on this cutoff
ratio, a total of 242 cDNAs, of which 87 represent known
genes and 155 unknown genes or expressed sequence tags
(ESTs) cDNAs, were differentially expressed between the
nontumorigenic KAd5 and the tumorigenic F10-12 cell
lines. Forty-four of the 87 known genes displayed higher
expression in KAd5 compared with F10-12, with the re-
maining genes showing opposite expression patterns.
Among the 155 unknown genes, 96 were expressed higher
in KAd5 cells, whereas 59 were up-regulated in the F10-12
tumorigenic cell line. Importantly, as shown in the histo-
gram of Fig. 1B, the majority (97%) of the clones with
detectable signals was expressed at similar levels in both
cell lines.
To analyze the data obtained by microarray analysis, we
categorized the differentially expressed known genes ac-
cording to their basic functions. As shown in Table 2, most
of the known genes are involved in signal transduction, cell
growth and proliferation, cell cycle, transcription regula-
tion, protease, and immune functions. For example, in the
category of cell growth and proliferation, B cell transloca-
tion gene 2 (BTG2), Ufo/Axl gene and transforming growth
factor beta 2 gene are up-regulated in the Ad5-TC compared
with the Ad12-TC. Conversely, several growth factor bind-
ing protein genes such as insulin-like growth factor binding
protein 5 gene and growth factor receptor binding protein
(Grb10) gene are up-regulated in the Ad12-TC compared
with the Ad5-TC. Other candidate tumor-related genes
showing differential expression in the two cell lines include
cytoskeleton genes (e.g., troponin I) and the tumor marker
gene (L6 antigen). In addition, more than 150 uncharacter-
Table 1
Adenovirus-transformed BALB/c mouse cell lines used in this study
Cell line Tissue of origin Microarray Northern blot
Ad5-TC





F10-12 Kidney  
Bem12-3 Embryo 
12A1 Brain 
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ized ESTs were identified as being differentially regulated,
indicating that a considerable number of novel genes may
be involved in Ad12-induced tumorigenesis (Table 2). It is
noted that the GEM microarray does not contain cDNAs of
MHC class I or COUP-TFII, which are known to be differ-
entially expressed between the two cell lines (reviewed in
Ricciardi, 1999; Smirnov et al., 2001).
In several cases, a single gene was represented by two or
more cDNA sequences on the microarray. For each of these
multiple representations, a similar differential expression
ratio was obtained. For example, protease-nexin 1 (PN-1)
gene is represented by two sequences that produce differ-
ential expression ratios of 3.9 and 4.3, respectively (see
Table 2 under the category of Protease function). These
results demonstrate that the microarray data, per se, are
reproducible.
Validation of microarray by Northern blot analyses
Northern blot analysis was used to confirm the differen-
tial expression of genes identified by the microarray. First,
we performed Northern blot analysis on mRNAs derived
from the same two cell lines (F10-12 and KAd5) that were
examined by the microarray. For probes, we selected 22
cDNAs with known or suspected functions in tumorigenesis
with the aim to validate the microarray as well as to dis-
cover new genes that may play a role in Ad12 tumorigen-
esis. All of the 22 cDNA probes were verified by DNA
sequencing. Half of the 22 genes chosen for Northern blot
analysis was expressed higher in the tumorigenic F10-12
cells, whereas the other half was expressed more in the
nontumorigenic KAd5. The mRNA expression levels from
the Northern blot analysis were quantified and differential
expression ratios were calculated as described under Mate-
rials and methods.
The results demonstrated that 16 (73%) of the 22 genes
analyzed have expression trends that are consistent with the
microarray analysis; specifically, eight genes exhibited
higher expression in KAd5 and the other eight genes exhib-
ited higher expression in F10-12 (Table 3, Group I). Con-
versely, the expression patterns of 6 (27%) of the 22 genes
analyzed by Northern blot were in disagreement with that of
the microarray (Table 3, Group II). In addition to the 22
cDNAs, two EST genes that showed no differential expres-
sion between KAd5 and F10-12 by microarray analysis, also
had equal or nearly equal expression levels by Northern blot
analysis (Table 3, Group III). Even though the expression
tendencies for the majority of the 22 genes identified by
microarray were confirmed, quantitative differences in ex-
pression as determined by Northern blot analyses rarely
matched the microarray data. For example, both microarray
and Northern blot indicated that PN-1 gene expression is
higher in Ad12-TC than in Ad5-TC. However, the Northern
blot suggested that this difference in PN-1 gene expression
is 11-fold higher than that indicated by the microarray.
These results indicate that the differential expression trend
as revealed by our microarray is valid for about 75% of the
genes and that Northern blot, which provides confirmation
of the microarray, is quantitatively more reliable.
Identification of three highly differentially expressed
genes associated with Ad12 tumorigenesis
The Northern blot analyses summarized in Table 3 val-
idated the differential expression for a subset of genes
(Group I) between the two cell lines (KAd5 and F10-12)
analyzed by the microarray. Certain of these genes are
highly differentially expressed between KAd5 and F10-12
and thus may be involved in Ad12 tumorigenesis. To sub-
stantiate this possibility, differential gene expression pat-
terns need to be demonstrated in a consistent manner be-
tween multiple Ad5-TC and Ad12-TC. We thus performed
Northern blot analyses on three additional Ad5-TC and two
Fig. 1. cDNA microarray analysis of differential gene expression between
nontumorigenic Ad5-TC and tumorigenic Ad12-TC. (A) Summary of the
mouse GEM microarray analysis. (B) Distribution of the number of genes
based on their differential expression ratios in Ad5-TC (KAd5) relative to
Ad12-TC (F10-12). A positive ratio represents higher expression in Ad5-
TC, whereas a negative value denotes more expression in Ad12-TC.
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Table 2
Genes differentially expressed in Ad5-TC and Ad12-TC as identified by microarray
Categorya Ratiob IMAGE IDc Gene name
Signal transduction
6.5 875444 G protein-coupled receptor kinase 5 (GRK5)
2.4 374248 Cyclic nucleotide phosphodiesterase 1
2.3 575665 MAP kinase phospharase-1
2.3 476416 CD151 antigen
2.1 723208 Putative G protein-coupled receptor TDAG8
2.8 890444 GTP binding protein (GTP2) mRNA
Cell growth/proliferation
5 820167 Insulin-like growth factor binding protein 10
4.8 678991 Kallikrein-3, plasma
4.7 778590 p53 responsive (EI24) mRNA
3.4 583186 B-cell translocation gene 2 (BTG2), anti-proliferative
3.4 403597 Bone morphogenatic protein 1
3.3 420323 Mouse 19.5 mRNA
3.3 401608 Ufo/Axl oncogene homolog
3 617388 Myaloid/lymphoid or mixed-lineage leukemia
3 532350 Integral membrane protein 2
2.7 367780 Transforming growth factor, beta 2
2.7 329866 Kallikrein-3, plasma
2.3 678793 Pituitary tumor transforming gene protein
2.2 479758 Fibroblast growth factor 15
2.2 409069 Transformation related protein 53
2.2 438917 Unc-51 like kinase 1
2.1 671910 Follistatin-like
2.1 418952 Insulin-like growth factor binding protein 5
2.1 716630 mRNA for Pr22 protein
2.3 572275 Neurofibromatosis 2
3.3 746564 Growth factor receptor binding protein 10 (Grb10)
3.4 671661 Insulin-like growth factor binding protein 5
Cell cycle 2.1 477516 mRNA for CDC6 protein
Transcription 2.3 672424 GATA-binding protein 4
2.2 315058 SRY-box containing gene 4
2.1 333683 FK506-binding protein precursor
2.4 458432 mRNA for transcription factor TFIIH, 62-KD subunit
2.3 779876 Metal response element DNA-binding protein M96 mRNA
3 333376 A10 mRNA
3.6 385441 A10 mRNA
Protease function
2.4 876328 Cathepsin C
2.2 680455 Proprotein convertase subtilisin/kexin type 3
3 747101 mRNA for calpain-like protease
3.2 478504 mRNA for calpain-like protease
3.9 464497 Protease nexin 1 (PN-1), serine protease inhibitor 4
4.3 694987 Protease nexin 1 (PN-1)
Immune function
4 680815 Beta-getactoside binding lectin mRNA
3.8 533003 Stromal cell derived factor 1
2.1 354318 Pentaxin related gene
2.2 597054 Major histocompatibility locus class II region
2.3 421150 CD24a antigen
Cytoskeleton
20 426504 Troponin 1, skeletal, fast 2
9.3 388916 Keratin complex 1, acidic, gene 10
2.2 482602 Tubulin, beta 2
2.8 314850 Coiled-coil-like protein
Tumor marker
2.1 733601 L6 antigen mRNA
Miscellaneous
5.3 336536 3-phosphoadenosine 5-phosphosulfate synthase 2
3.4 336727 mRNA for tructose 1,6-bisphosphatase
2.9 333102 mRNA for synaptogyrin 2
2.9 697010 Transcobalmin II (Tcn2) mRNA
(continued on next page)
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Table 2 (continued)
Categorya Ratiob IMAGE IDc Gene name
2.5 481883 Sialytransferase 1
2.2 535199 mRNA for s17 protein
2.1 348123 mRNA for s17 protein
2.1 639442 Acid beta glucosidase
2.1 607469 Nucleoside phosphorylase
2.1 484259 Mannosidase 2, alpha B1
2.1 671205 Delta-aminolevulinate dehydratase
2.1 482369 ATP-binding cassette 1
2.1 733810 Elongation factor 1-beta homolog mRNA
2.2 459599 Mannosidase 2, alpha B1
2.2 480068 Metallothionein 1
2.2 318642 Hexokinase 1
2.3 438774 Carbon catabolite repression 4 homolog (S. cerevisiae)
2.3 571621 Prostaglandin D2 synthase (21 kDa, brain)
2.3 733420 Neoronal protein 3.1
2.6 419421 3-phosphoadenosine 5-phosphosulfate synthase 1
2.8 716896 Ribosomal protein L8 (RPL8) mRNA
2.6 551184 Glutathione peroxidase 3
2.7 448084 Very low density lipoprotein receptor
3 423156 Betaine homocysteine methyl transferase (BHMT) mRNA
3 535188 Phosphoribosylglycinamide formyltransferase
3.1 367627 Glutathione-S-transferase, alpha 1 (Ya)
3.3 641608 Cleavage and polyadenylation specificity factor mRNA
3.3 425866 Neuronal protein 3.1
3.4 762306 T-complex testis expressed 1
3.5 889543 Heat shock protein, 74 kDa
3.6 406031 NAD-dependent methylenetetrahydrofolate dehydrogenase
3.7 374970 Neuronal protein 3.1
4.2 426976 Branched chain aminotransferase 1, cytosolic
5.7 777018 mRNA for selenoprotein P
7 337748 Asparagine synthetase mRNA
24 656654 Aquaporin 1*
ESTs/unknown genes
11 619418 ESTs
11 403869 ESTs, highly similar to beta crystallin A4 (Bos taurus)
10 888553 ESTs, highly similar to gene with IMAGE ID 4426629 [R. norvegicus]
6 596893 ESTs
4.5 440103 5 reads not in UniGene cluster
3.9 479027 ESTs, highly similar to interferon-inducible protein [R. norvegicus]
3.9 805250 ESTs
3.9 332396 5 reads not in UniGene cluster
3.9 599093 ESTs, weakly similar to T2
3.8 653561 5 reads not in UniGene cluster
3.6 426965 ESTs, weakly similar to actin polymerization inhibitor [G. gallus]
3.6 387284 ESTs, weakly similar to cytoskeletal protein
3.6 597797 ESTs
3.5 336542 5 reads not in UniGene cluster
3.5 637305 5 reads not in UniGene cluster
3.4 718665 5 reads not in UniGene cluster
3.3 332181 5 reads not in UniGene cluster
3.2 332667 5 reads not in UniGene cluster
3.1 483024 ESTs
3 385914 5 reads not in UniGene cluster
3 427289 ESTs
3 476055 5 reads not in UniGene cluster
3 479042 ESTs, highly similar to the ha3523 gene product [H. sapiens]
2.9 894180 5 reads not in UniGene cluster
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Table 2 (continued)
Categorya Ratiob IMAGE IDc Gene name
2.6 835756 ESTs, highly similar to DTDP-4-dehydrothamnose reductase [S. typhimurium]
2.6 634338 ESTs
2.6 404339 ESTs
2.6 313686 5 reads not in UniGene cluster
2.6 315775 ESTs, highly similar to endothelial actin-binding protein [H. sapians]
2.6 642204 5 reads not in UniGene cluster
2.6 621630 ESTs
2.6 677592 ESTs
2.8 636193 5 reads not in UniGene cluster




2.5 436967 5 reads not in UniGene cluster
2.5 779034 5 reads not in UniGene cluster
2.5 596620 ESTs
2.5 478521 ESTs, highly similar to glycine amidinotransferase precursor [R. norvegicus]
2.4 890760 ESTs
2.4 334077 ESTs, moderately similar to fork head domain protein FKHR [H. sapiens]
2.4 419146 ESTs
2.4 764212 ESTs
2.4 636640 5 reads not in UniGene cluster
2.4 660979 5 reads not in UniGene cluster
2.4 438351 5 reads not in UniGene cluster
2.4 571803 5 reads not in UniGene cluster
2.3 808594 ESTs
2.3 620795 ESTs, moderately similar to cell surface glycoprotein MAC-1 alpha subunit precursor [M. musculus]
2.3 426493 ESTs
2.3 582499 ESTs, moderately similar to Ski oncogene [H. sapiens]
2.3 482136 5 reads not in UniGene cluster
2.3 677402 ESTs, moderately similar to clone 4240285 [H. sapiens]
2.3 421476 ESTs, weakly similar to interferon-induced protein 6–16 precursor [H. sapiens]
2.3 465043 5 reads not in UniGene cluster
2.3 820417 5 reads not in UniGene cluster
2.3 438478 5 reads not in UniGene cluster
2.3 336399 ESTs, weakly similar to B0414.8 (C. elegans)
2.3 719264 ESTs
2.3 481738 ESTs, moderately similar to human ZFY protein
2.3 573365 ESTs
2.2 439763 5 reads not in UniGene cluster
2.2 765332 ESTs




2.2 870973 ESTs, weakly similar to consensus repeat domain: nt 120–174 [R. norvegicus]
2.2 679316 ESTs, weakly similar to breast cancer supprassor candidate 1 [H. sapiens]
2.2 423948 5 reads not in UniGene cluster
2.2 894169 ESTs
2.2 335055 ESTs, highly similar to fibrinogen gamma-A chain precursor [H. sapiens]
2.2 474388 ESTs, highly similar to keratin, type II cytoskeletal 4 [H. sapiens]
2.1 439362 ESTs
2.1 445988 5 reads not in UniGene cluster
2.1 475797 5 reads not in UniGene cluster
2.1 722330 ESTs
2.1 425777 ESTs
2.1 656945 ESTs, highly similar to gene with IMAGE ID 4138824
2.1 334918 ESTs
2.1 617919 5 reads not in UniGene cluster
2.1 750198 ESTs
2.1 418462 ESTs, weakly similar to butyrophilin [H. sapiens]
2.1 466781 ESTs, highly similar to zinc finger protein 7 [H. sapiens]
2.1 330871 5 reads not in UniGene cluster
2.1 482952 ESTs, highly similar to nuclear factor NF-kappa-B P100 subunit [H. sapiens]
2.1 480568 ESTs
(continued on next page)
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Table 2 (continued)
Categorya Ratiob IMAGE IDc Gene name
2.1 571643 ESTs
2.1 426166 5 reads not in UniGene cluster
2.1 677033 ESTs, weakly similar to nucleotide translocator [C. elegans]
2.1 818293 ESTs
2.1 535388 ESTs, moderately similar to KIAA0281 [H. sapiens]
2.1 405994 5 reads not in UniGene cluster
2.1 524792 ESTs, highly similar to hypothetical 44.2–KDa protein in SCO2-MRF1 intergenic region [S. cerevisiae]
2.1 533314 ESTs, highly similar to maternal effect protein staufen [D. melanogaster]
2.1 576068 5 reads not in UniGene cluster
2.2 438604 ESTs
2.2 402053 ESTs, highly similar to protein phosphatase inhibitor 1 [R. norveqicus]
2.2 418527 5 reads not in UniGene cluster
2.2 455866 5 reads not in UniGene cluster
2.2 620101 5 reads not in UniGene cluster
2.2 617247 ESTs, weakly similar to predicted using Genefinder [C. elegans]
2.2 618611 ESTs
2.2 733726 5 reads not in UniGene cluster
2.2 535645 ESTs
2.2 523241 ESTs
2.2 353317 5 reads not in UniGene cluster
2.3 350904 5 reads not in UniGene cluster
2.3 426172 ESTs
2.3 445707 5 reads not in UniGene cluster
2.4 733438 ESTs
2.4 638783 ESTs
2.4 457253 5 reads not in UniGene cluster
2.4 536577 5 reads not in UniGene cluster
2.4 532659 ESTs, highly similar to (define not available 4426565) [R. norvegicus]
2.4 455438 5 reads not in UniGene cluster
2.5 961094 ESTs
2.5 456831 5 reads not in UniGene cluster
2.6 661504 ESTs, weakly similar to F52C12.2 [C. elegans]
2.8 390313 ESTs, highly similar to fructose-biphosphate
2.6 871020 ESTs, highly similar to NADH-ubiquinone oxidoreductase B14 subunit [Bos taurus]
2.6 476408 5 reads not in UniGene cluster
2.7 315676 5 reads not in UniGene cluster
2.8 482972 5 reads not in UniGene cluster
2.9 804963 ESTs, weakly similar to (define not available 3874391) [C. elegans]
2.9 763647 ESTs, highly similar to ubiquitin carboxyl-terminal hydrolase isozyme L1 [R. norvegicus]
3 315536 5 reads not in UniGene cluster
3.1 457532 5 reads not in UniGene cluster
3.2 456064 ESTs, weakly similar to B0414.8 [C. elegans]
3.5 443806 5 reads not in UniGene cluster
3.5 679235 ESTs, highly similar to crystathionine gamma-lyase [H. sapiens]
3.5 851585 5 reads not in UniGene cluster
3.6 805842 ESTs, highly similar to putative asparaginyl-tRNA synthetase DED81 [S. cerevisiae]
3.7 816807 ESTs
3.7 748061 ESTs, weakly similar to (define not available 3874391) [C. elegans]
3.8 419138 ESTs
3.8 676311 ESTs, highly similar to serine hydroxymethyl transferase, mitochondrial [O. cunicutus]
3.9 791618 5 reads not in UniGene cluster
3.9 480488 ESTs, highly similar to threonyl-tRNA sythalase, cyloplasmic [H. sapins]
3.9 746853 ESTs, highly similar to probable phosphoserine aminotransferase [O. cuniculus]
4.3 642223 5 reads not in UniGene cluster
4.5 572819 ESTs
4.6 780337 ESTs
4.6 573784 ESTs, highly similar to probable phosphoserine aminotransferase [O. cunicutus]
5.5 525119 ESTs, highly similar to crystathionine gamma-lyase [H. sapiens]
6.1 456481 5 reads not in UniGene cluster
26 522713 5 reads not in UniGene cluster
a Known genes are categorized based on their basic functions. We found by DNA sequencing that aquaporin 1 cDNA (marked with an asterisk) is a
chimeric consisting of a portion of aquaporin 1 and sequences highly homologous to a retrovirus gene.
b Differential gene expression ratios between Ad5-TC (KAd5) and Ad12-TC (F10-12). A positive value represents higher expression in KAd5, whereas
a negative ratio means more expression in F10-12.
c IMAGE clone identification for differentially expressed genes.
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additional A12-TC listed in Table 1. It is noted that RNA
from primary BALB/c brain and kidney cells was also
included in each Northern blot since all but one of the
transformed cell lines were derived from these tissues (Ta-
ble 1). Using this approach, three genes that may be in-
volved in Ad12 tumorigenesis have been identified and are
described below.
The first gene is Grb10, which is dramatically overex-
pressed in Ad12-TC. As shown in the Northern blot of Fig.
2, mRNA expression of Grb10 was significantly up-regu-
lated in the panel of tumorigenic Ad12-TC (lanes 7–9)
relative to the extremely low levels of expression in the
panel of nontumorigenic Ad5-TC (lanes 3–6). As in the
Ad5-TC, Grb10 expression was also very low in primary
cells from kidney and brain (Fig. 2, lanes 1 and 2). The
potential importance of Grb10 to Ad12 tumorigenesis is
underscored by the fact that its strong expression is consis-
tent among the three Ad12-TC examined and is independent
of the tissue origin from which these cell lines were gener-
ated (Table 1). These results infer that the increase in Grb10
expression is directly related to the viral oncogenes of
Ad12. How might the overexpression of Grb10 be linked to
the tumorigenic phenotype of Ad12-TC? Grb10 is a mem-
ber of a superfamily of adapter proteins that function as
downstream effectors of growth factor activated receptor
tyrosine kinases (reviewed by Han et al., 2001; Morrione,
2000). One natural function described for Grb10 is its par-
ticipation in vasculogenesis and angiogenesis mediated by
vascular endothelial growth factor (VEGF) (Giorgetti-
Peraldi et al., 2001). In addition, Grb10 can be enacted upon
by other growth factors including platelet-derived growth
factor BB (PDGF-BB), insulin, and insulin-like growth fac-
tor (IGF) (Wang et al., 1999). It will be important to learn
how these growth factor functions of Grb10 are involved in
tumorigenesis and, in particular, whether Grb10 is respon-
sible for inducing a blood supply to Ad12 tumors.
The second gene, PN-1, is also significantly expressed in
Ad12-TC. As shown in the Northern blot of Fig. 2, expres-
sion of PN-1 mRNA is considerable in each of the Ad12-TC
(lanes 7–9) as well as in primary brain cells (lane 2). By
contrast, expression of PN-1 is negligible in all of the Ad5
TC (Fig. 2, lanes 3–6) and in the primary kidney cells (lane
1). As with Grb10, this nearly “all or none” expression
pattern of PN-1 between tumorigenic Ad12-TC and nontu-
Table 3
Comparison of differential expression ratios determined by microarray and Northern blot analyses
Gene namea IMAGE IDb KAd5/F10–12c
Microarray Northern blot
Group I. Consistent in gene expression trends
ESTs, highly similar to stress-induced protein (SIP) 619418 11.0 4.2
p53 responsive mRNA 778590 4.7 1.1
ESTs, highly similar to human interferon-inducible protein 479027 3.9 5.7
B-cell translocation gene 2 (BTG2)* 583186 3.4 5.1
Ufo/Axl oncogene homolog 401608 3.3 17.5
ESTs, moderately similar to Ski oncogene 582499 2.3 1.3
MAP kinase phosphatase-1 575665 2.3 1.2
Pituitary tumor transforming gene 678793 2.3 2.2
Insulin-like growth factor binding protein 5 418952 2.1 2.3
ESTs, 5 reads not in UniGene cluster 315676 2.7 3.6
Growth factor receptor binding protein 10 (Grb10)* 746564 3.3 13.0
Insulin-like growth factor binding protein 5 671661 3.4 1.4
ESTs 419138 3.8 7.2
Protease nexin 1 (PN-1)* 694987 4.3 47.5
ESTs 572819 4.5 1.2
ESTs 780337 4.8 1.0
Group II. Inconsistent in gene expression trends
ESTs 596893 6.0 2.1
Insulin-like growth factor binding protein 10 820167 5.0 1.6
Transforming growth factor, beta 2 367780 2.7 17.5
Neurofibromatosis 2 (Nf-2/merlin) 572275 2.3 2.1
Heat shock protein, 74 kDa 889543 3.5 1.1
mRNA for selenoprotein P 777018 5.7 1.0
Group III. Control
ESTs 733832 1.0 1.6
ESTs 752174 1.0 1.0
a Genes are grouped based on expression trends in KAd5 relative to F10–12 derived from microarray and Northern blot analyses. The three highly
differentially expressed genes as determined by Northern blot analyses between multiple Ad5-TC and Ad12-TC are marked by asterisks (see Fig. 2).
b IMAGE clone identification for genes subjected to Northern blot analyses.
c Differential gene expression ratios obtained by microarray and Northern blot analyses. A positive value represents higher expression in KAd5, whereas
a negative ratio means more expression in F10–12.
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morigenic Ad5-TC suggests that this gene likely also plays
an important role in viral tumorigenesis. PN-1, a member of
the serine protease inhibitor (serpin) superfamily, is a potent
inhibitor of thrombin, plasmin, urokinase, and plasminogen
activators (Gloor et al., 1986). These serine proteases are
involved in extracellular matrix (ECM) proteolysis, a pro-
cess that is required for angiogenesis and metastasis (re-
viewed in Pepper, 2001; Rabbani and Mazar, 2001). There-
fore, proteolytic regulation by PN-1 can modulate the
interaction of tumor cells with ECM. It has been found that
expression of PN-1 is elevated in brain tumors and liposar-
coma (Rao et al., 1990; Thelin-Jarnum et al., 1999). Nor-
mally, PN-1 appears to play an important role in the devel-
opment and maintenance of neuronal cells (reviewed in
Turgeon and Houenou, 1997). This provides an explanation
as to why this gene is highly expressed in primary brain
cells of mouse as revealed in the Northern blot (Fig. 2, lane
2) and rat (Reinhard et al., 1994). By inhibiting serine
proteases, PN-1 is thought to promote neurite outgrowth
and to prevent neuronal cell death (Suidan et al., 1992;
reviewed in Turgeon and Houenou, 1997). Is there a con-
nection between PN-1 expression in Ad12-TC and neuronal
cells? It has been recently found that Ad12-induced tumors
have a pathology that is characteristic of primitive neuro-
ectodermal tumors and express several neuronal-specific
genes including enolase and syaptophysin (Hohlweg et al.,
unpublished data). In addition, as with neuronal cells,
Ad12-TC have reduced expression of MHC class I on cell
surface (reviewed in Ricciardi, 1999). Moreover, our mi-
croarray data also indicate that neuronal-specific genes,
neurofibromatosis 2 and neuronal protein 3.1, are overex-
pressed in Ad12-TC (Table 2). Collectively, these results
substantiate that Ad12-TC express neuronal gene markers.
The Ad12-TC may utilize the neuronal expression patterns
for tumor survival, e.g., MHC class I down-regulation and
escape from immune surveillance. Excitingly, this microar-
ray study has discovered at least one new neuronal marker
gene, PN-1, that may participate in Ad12 tumorigenesis.
The third gene is BTG2, also referred to as PC3 or TIS21
(see review in Tirone, 2001). As shown in the Northern blot
of Fig. 2, BTG2 expression was consistently higher in the
panel of nontumorigenic Ad5-TC compared to the panel of
tumorigenic Ad12-TC. This difference occurred regardless
of the tissue origin from which the transformed cell lines
were derived (Table 1). Expression of BTG2 was only
marginal in each of the three Ad12-TC (Fig. 2, lanes 7–9) as
well as in primary kidney and primary brain cells (lanes
1–2). In contrast, BTG2 was clearly up-regulated in the four
Ad5-TC, albeit, the expression levels varied among the cell
lines within this panel (Fig. 2, lanes 3–6). BTG2 is the
prototypic member of a novel family of genes involved in
antiproliferation and functions by maintaining growth-sup-
pressing pRB in its active hypophosphorylated form (re-
viewed in Tirone, 2001). Specifically, BTG2 inhibits cyclin
D1 transcription, resulting in the inactivation of cyclin-
dependent kinase 4 and the subsequent hypophosphoryla-
tion of pRB. Since the antiproliferation function of BTG2 is
not consistent with transformation, why is this gene up-
regulated in Ad5-TC? All adenovirus transformed cells,
including Ad5-TC, are able to block pRB and p53 functions
via their E1A and E1B transforming genes, respectively.
These viral proteins may override the antiproliferative func-
tion of BTG2 in Ad5-TC. Using CtBP suppression of Ad5
E1A tumorigenesis as a precedent (reviewed in Chinnadu-
rai, 2002), it is intriguing to consider that high BTG2 ex-
pression in Ad5-TC may also participate in suppression of
tumorigenesis. It is noted that BTG2 is a marker of neuronal
birth (reviewed in Tirone, 2001) and is expressed at very
low levels in mature neuronal cells (Melamed et al., 2002).
Whether the low levels of BTG2 in both brain and Ad12-TC
(Fig. 2, compare lane 2 with 7–9) are relevant, has yet to be
determined, especially since the expression level of this
gene is also low in primary kidney cells (lane 1).
Summary
In addition to the expression of transforming genes that
trigger cellular immortalization, tumorigenesis requires the
expression of other genes that provide the transformed cell
with the ability to escape immune surveillance and the
Fig. 2. Northern blot analyses of representative genes that are highly
differentially expressed between nontumorigenic Ad5-TC and tumorigenic
Ad12-TC. Indicated above each lane are the names of primary and ade-
novirus transformed cells from which RNA was extracted. Indicated to the
left of each blot are the cDNAs used as probes: Grb10, growth factor
receptor binding protein 10; PN-1, protease nexin 1; and BTG2, B cell
translocation gene 2. As a control for RNA loading, each blot was reprobed
with RNase P (rp).
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physiological capacity to successfully develop into a tumor.
For example, MHC class I down-regulation and angiogen-
esis are essential to the survival of many tumors. In this
study, we compared the cDNA microarray profiles of non-
tumorigenic Ad5 and tumorigenic Ad12-transformed cells
to identify highly differentially expressed genes that are
associated with Ad12 tumorigenesis. Here, the cDNA mi-
croarray proved to be powerful in that it enabled us to
identify several new genes that may contribute to generation
of Ad12 tumors. Northern blot analyses of panels of ade-
novirus-transformed cells show the consistent up-regulation
of Grb10 and PN-1 in Ad12-transformed cells and of BTG2
in Ad5-transformed cells. While the function of these genes
in Ad12 tumorigenesis remains to be elucidated, it is in-
triguing to consider that Grb10 may be involved in tumor
angiogenesis and that PN-1 may regulate the interaction of
tumor cells with ECM. PN-1, which is known to function in
neuronal development, is especially interesting because it
becomes the newest of several neuronal markers that are
characteristic of Ad12 tumorigenic cells. In addition to the
three highly differentially expressed genes, Northern blot
analyses also showed that Ax1, and two EST genes
(IMAGE IDs: 479027 and 619418), were generally ex-
pressed at a higher level in Ad5- than in Ad12-transformed
cells (data not shown). Since in this study, only a subset
(about 10%) of the differentially expressed genes identified
by the cDNA microarray were examined by Northern blot,
we anticipate that at least several more tumor-associated
genes remain to be discovered.
Materials and methods
Cell lines
Four Ad5-TC (KAd5, 5DNA1, Wt5a, and BrAd5) and
three Ad12-TC (F10-12, Bem12-3, and 12A1) were derived
from mouse BALB/c primary cells as previously described
(Eager et al., 1985). The cells were cultured in Eagle’s
minimal essential medium (Biowhittaker) supplemented
with 10% fetal bovine serum, 2 mM L-glutamine, and 50
g/ml gentamycin sulfate (Gibco-BRL).
RNA preparation
Total RNA was prepared from each cell line using
RNeasy kit (Qiagen, Inc.). The RNA was then precipitated
with ethanol and redissolved in DEPC-treated ddH2O. Total
RNAs from primary cells of mouse BALB/c kidney and
brain were purchased from Stratagene.
cDNA microarray analysis
RNA prepared from two haplotypically matched cell
lines (KAd5 and F10-12) was used to generate cDNA
probes labeled with fluorescent dyes of either Cyanine 3
(Cy3) or Cyanine 5 (Cy5). The probes were then hybridized
to a Mouse GEM microarray (Incyte Pharmaceuticals),
which contained 8734 cDNAs that represent 7854 unique
genes and was created using known mouse genes as well as
ESTs from the IMAGE Consortium collection. Differences
in expression levels between KAd5 and F10-12 cells were
measured as Cy3/Cy5 fluorescence ratios after normaliza-
tion to the inherent fluorescence differences between the
two dyes. (Please see web page http://www.incyte.com/
gem/technology for more information.)
Northern blot analysis
Twenty micrograms of total RNA from each cell type
was fractioned on 1.2% agarose formaldehyde gel electro-
phoresis and transferred onto nylon membranes. The RNA
blots were then hybridized with 32P-labeled probes synthe-
sized from array cDNAs by polymerase chain reaction or
random primer labeling. The cDNAs were confirmed by
sequencing. As a gel loading control, the same blots were
reprobed with radiolabeled cDNA of RNase P. Expression
levels were quantified using PhosphoImager (Molecular
Dynamics) and gene expression ratios between Ad5-TC and
Ad12-TC were calculated. The ratios were averaged when
two or more Northern blot analyses were conducted for the
same genes.
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